KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $542.0 million.

  • Amgen's Shares Outstanding (Diluted Average) changed 0.0% to $542.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $542.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $541.0 million for FY2024, which is 55.76% up from last year.
  • As of Q3 2025, Amgen's Shares Outstanding (Diluted Average) stood at $542.0 million, which was down 0.0% from $541.0 million recorded in Q2 2025.
  • Over the past 5 years, Amgen's Shares Outstanding (Diluted Average) peaked at $581.0 million during Q1 2021, and registered a low of $536.0 million during Q1 2024.
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $541.0 million (2022), whereas its average is $548.5 million.
  • In the last 5 years, Amgen's Shares Outstanding (Diluted Average) plummeted by 590.28% in 2022 and then surged by 93.28% in 2025.
  • Amgen's Shares Outstanding (Diluted Average) (Quarter) stood at $573.0 million in 2021, then dropped by 5.58% to $541.0 million in 2022, then dropped by 0.55% to $538.0 million in 2023, then increased by 0.56% to $541.0 million in 2024, then increased by 0.18% to $542.0 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $542.0 million in Q3 2025, compared to $541.0 million in Q2 2025 and $541.0 million in Q1 2025.